AEGiS-UNAIDS: 11th European AIDS Conference opens in Madrid UNAIDSImportant note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
Click here to return to UNAIDS main menu
DonateNow
Print this Article


11th European AIDS Conference opens in Madrid

UNAIDS - October 24, 2007


The 11th European AIDS Conference runs from 24-27 October in Madrid, Spain. The conference, held every other year and attended by several thousand delegates, focuses on issues related to HIV clinical research and care in Europe.

In a special session titled "What's New in HIV Prevention", UNAIDS Chief Scientific Advisor, Catherine Hankins will address the conference on Thursday 24 with a presentation about ethical issues related to research into biomedical HIV prevention methods, which include pre-exposure prophylaxis (the use of HIV medicines to prevent infection), male circumcision and microbicides.

Other sessions will focus on topics such as the impact and complications of HIV treatment, issues facing older patients, Hepatitis co-infection, HIV drug resistance and implementation of the European HIV treatment guidelines. A number of pharmaceutical research and development companies who are sponsoring the conference will conduct satellite symposia throughout the event to discuss their companies' treatment advances.

The conference is organized by the European AIDS Clinical Society, which published the first common European treatment guidelines in 2001 in recognition of the need for standard treatment protocols across the continent. The guidelines were updated in 2005, and another update will be made available on the final day of the Madrid conference.

Previous conferences have been held in cities across Europe since 1989, most recently taking place in Dublin in 2005. The 12th European AIDS Conference is planned for Cologne, Germany in November 2009.


071024
UN071007


Copyright © 2007 - Joint United Nations Programme on HIV/AIDS (UNAIDS). All rights reserved. UNAIDS articles, which are not formal publications of UNAIDS, may be freely reviewed, quoted, reproduced or translated, in part or in full, provided the source is acknowledged. The documents may not be sold or used in conjunction with commercial purposes without prior written approval from UNAIDS (contact: UNAIDS Information Centre).

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .